Sutton Wealth Advisors’s Biogen BIIB Stock Holding History

Sutton Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$8.48K	Buy	33 +10	+43%	+$2.67K	﹤0.01%	506
2023 Q2	$6.55K	Sell	23 -3	-12%	-$893	﹤0.01%	524
2023 Q1	$7.23K	Sell	26 -840	-97%	-$232K	﹤0.01%	476
2022 Q4	$240K	Buy	866 +6	+0.7%	+$1.7K	0.09%	152
2022 Q3	$230K	Sell	860 -13	-1%	-$2.76K	0.09%	153
2022 Q2	$178K	Sell	873 -26	-3%	-$5.32K	0.07%	178
2022 Q1	$189K	Buy	899 +13	+1%	+$2.83K	0.07%	187
2021 Q4	$213K	Sell	886 -5	-0.6%	-$1.29K	0.07%	172
2021 Q3	$252K	Sell	891 -2	-0.2%	-$656	0.09%	150
2021 Q2	$309K	Buy	893 +3	+0.3%	+$909	0.11%	127
2021 Q1	$249K	Buy	890 +4	+0.5%	+$1.08K	0.1%	144
2020 Q4	$217K	Buy	886 +3	+0.3%	+$774	0.09%	149
2020 Q3	$250K	Sell	883 -1	-0.1%	-$279	0.12%	125
2020 Q2	$237K	Buy	884 +3	+0.3%	+$902	0.12%	124
2020 Q1	$279K	Buy	881 +3	+0.3%	+$910	0.18%	97
2019 Q4	$261K	Hold	878	–	–	0.13%	125
2019 Q3	$204K	Hold	878	–	–	0.11%	144
2019 Q2	$205K	Sell	878 -3	-0.3%	-$693	0.12%	139
2019 Q1	$208K	Buy	881 +4	+0.5%	+$1.26K	0.12%	135
2018 Q4	$264K	Hold	877	–	–	0.17%	100
2018 Q3	$310K	Hold	877	–	–	0.2%	88
2018 Q2	$255K	Hold	877	–	–	0.18%	97
2018 Q1	$240K	Hold	877	–	–	0.17%	104
2017 Q4	$279K	Hold	877	–	–	0.2%	84
2017 Q3	$275K	Hold	877	–	–	0.21%	82
2017 Q2	$238K	Buy	877 +5	+0.6%	+$1.32K	0.19%	90
2017 Q1	$238K	Sell	872 -5	-0.6%	-$1.41K	0.2%	82
2016 Q4	$249K	Buy	877 +3	+0.3%	+$889	0.22%	77
2016 Q3	$274K	Buy	874 +5	+0.6%	+$1.48K	0.25%	69
2016 Q2	$210K	Buy	869 +3	+0.3%	+$791	0.2%	87
2016 Q1	$225K	Buy	+866	New	+$229K	0.21%	79

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sutton Wealth Advisors's BIIB Position: Q3 2023 in Review

Sutton Wealth Advisors increased its Biogen (BIIB) stake by 43% in Q3 2023, buying an estimated $2.67K and bringing the position to 33 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Sutton Wealth Advisors first reported a position in BIIB in Q1 2016 and has held it in 31 quarters since. The position peaked at $310K in Q3 2018. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Sutton Wealth Advisors held 33 shares of Biogen worth $8.48K as of Q3 2023.
Sutton Wealth Advisors bought 10 Biogen shares in Q3 2023, an estimated $2.67K.
Biogen made up ﹤0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #506 holding.
Sutton Wealth Advisors first reported a position in Biogen in Q1 2016 and has held it in 31 quarters since.
Sutton Wealth Advisors's Biogen position peaked at $310K in Q3 2018.
966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.